"Promoting and supporting research on diabetes
and metabolic diseases"

For the advancement of diabetes research

In the spotlight

‼️ IN THE PRESS ‼️

 

 

The recipients of the FFRD research grants are officially recognized:

  • Pierre GOURDY
  • Alfonso GALDERISI
  • Emmanuel COSSON

 

  • Le Monde
  • Diabète & Obésité
  • Équilibre…

 

🚦 Coming soon…  Publications and graphical abstracts of the recipients !

 

⏯️  DISCOVER THE NEW ARTICLES !

News

The upcoming events of the FFRD

10
Apr
Board Meeting

Feed-back of the SFD congress in Paris
Update on the ongoing call for projects
Latest press coverage
Financial update

10
Apr
Board of Directors Meeting

Approal of the FFRD’s strategic directions
Approval of accounts certified by our statutory auditor
Renewal of our partnerships and donors
Follow-up of projects and agreements of the recipients

Photo BV_Light

President’s foreword

The Francophone Foundation for Diabetes Research (FFRD) serves as the “armed wing” of the Francophone Diabetes Society (SFD) with the aim of promoting excellence in diabetes research, a common disease whose prevalence continues to rise. High-level and large-scale research is truly essential to get further insight into the mechanisms involved in the development of diabetes and its complications, as well as to improve their treatment and prevention.

The FFRD supports all research on diabetes.

The FFRD supports clinical, basic, and translational research.

The supported basic research projects address major themes of type 1 and type 2 diabetes

covering subjects such as pancreatic beta cells, insulin resistance, and intestinal microbiota.

The clinical research projects, on the other hand, address the themes of type 1 and type 2 diabetes, as well as gestational diabetes

and often involve large multicenter cohort studies.

Since 2013, the Foundation has been:

0
years of existence
0
teams of supported researchers
0
euros in annual grants
0
million of euros distributed
0
% of expenses allocated to research

The recipients of the year

Pierre GOURDY
Pierre GOURDY
Cardiovascular and Metabolic diseases Institute, Inserm, CHU in Toulouse
Translational Research Project
300 000
Alfonso GALDERISI
Alfonso GALDERISI
Robert Debré, Hospital, University Paris Cité
Clinical Research Project
300 000

They support us